session DESCRIPTION
Scott Gottlieb, MD, is a physician and served as the 23rd Commissioner of the U.S. Food and Drug Administration. He is currently a senior fellow at the American Enterprise Institute for Public Policy Research and a partner at the venture capital firm New Enterprise Associates. Under Dr. Gottlieb's leadership, the FDA advanced new frameworks for the modern oversight of gene therapies, cell-based medicines, and digital health devices. He promoted policies to reduce death and disease from tobacco, improve food safety, and aggressively confront addiction crises. The agency's prolific advances in new policy distinguished his tenure as FDA Commissioner, along with a record-setting number of approvals for novel drugs, medical devices, and generic medicines. Dr. Gottlieb is the author of the New York Times bestselling book Uncontrolled Spread: Why Covid-19 Crushed Us and How We Can Defeat the Next Pandemic and is a regular contributor to CNBC and CBS News' Face the Nation. In 2018 and again in 2019, Dr. Gottlieb was recognized by Fortune Magazine as one of "The World's 50 Greatest Leaders" and by Time Magazine as one of the "50 People Transforming Healthcare." Dr. Gottlieb is an elected member of the National Academy of Medicine and completed medical school and a residency in internal medicine at the Mount Sinai School of Medicine. He graduated from Wesleyan University, where he majored in economics, and currently serves on the university's board of directors. Dr. Gottlieb lives in Connecticut with his wife and three daughters.
learning objectives
- Discuss role of Radiation Oncology in the general schema of health care
- Assess how the profession of Radiation Oncology can advance patient care
Credits
| AMA PRA Category 1 Credits: | 1.00 |
Presentations
-
09:00am - 09:01am ETSpeaker: James Metz, MD - University of Pennsylvania, Philadelphia
-
09:01am - 10:00am ETSpeaker: Scott Gottlieb, MD - Partner, New Enterprise Associates; 23rd Commissioner of the U.S. Food and Drug Administration, New York